Effects of anti-TNF biologic drugs on uveitis severity in Behçet patients: systematic review and Meta-analysis
Author:
Corresponding Author:

Shahriar Alipour. Department of Clinical Biochemistry, Urmia University of Medical Sciences, Serrow-Nazloo Road, Urmia 5756115111, Iran. alipourshahriar17@gmail.com; alipour.sh@umsu.ac.ir

Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    AIM: To investigate effects of anti-TNF biologic drugs on uveitis severity (comparing visual acuity logMAR levels) in Behçet patients. METHODS: Three databases PubMed, Scopus, and the Web of Science were searched for qualified papers focusing on the anti-TNF-α factors treatment in Behçet’s disease (BD)-associated uveitis. Studies that were designed pre and post anti-TNF drug treatment, were selected. After determining the search strategy for this study, the relevant data were extracted. RESULTS: The initial search was performed in the target databases and a total of about 1458 articles were found. Fifteen articles were selected for systematic review and only 12 of them had inclusion criteria for Meta-analysis (with visual acuity data). The mean dose of prednisolone before and after biological treatments was reported in 5 studies (28.56 and 7.56 mg/kg, respectively). Also, the preliminary results indicate a significant reduction in visual acuity logMAR levels (MD=-1.5 IU/L, 95%CI: -2.1, -0.01). CONCLUSION: Biological drugs significantly reduce the dose of prednisolone and affect visual acuity values.

    Reference
    Related
    Cited by
Get Citation

Somayeh Abolhasani, Alireza Khabbazi, Foroogh Hosseini, et al. Effects of anti-TNF biologic drugs on uveitis severity in Behçet patients: systematic review and Meta-analysis. Int J Ophthalmol, 2022,15(5):813-819

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:May 28,2021
  • Revised:September 15,2021
  • Adopted:
  • Online: April 27,2022
  • Published: